Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Drug Safety|August 1, 1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorderL L Carpenter, C J McDougle, C N Epperson, et al.
Journal of Child and Adolescent Psychopharmacology|June 5, 1999
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three casesC N Epperson, D Fasula, S Wasylink, et al.
Biological Psychiatry|August 25, 1999
Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorderJ G Longhurst, L L Carpenter, C N Epperson, et al.
The Journal of Clinical Psychiatry|November 1, 1995
Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three casesC J McDougle, R L Fleischmann, C N Epperson, et al.
The Journal of Clinical Psychiatry|September 15, 1999
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case seriesE L Weiss, M N Potenza, C J McDougle, et al.
The Journal of Clinical Psychiatry|March 1, 1994
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorderC J McDougle, W K Goodman, L H Price
Pharmacopsychiatry|May 1, 1993
The pharmacotherapy of obsessive-compulsive disorderC J McDougle, W K Goodman, L H Price
Journal of Autism and Developmental Disorders|December 1, 1990
Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case reportC J McDougle, L H Price, W K Goodman
Pageof 19